Slides on Key Decisions in HIV Care: Polypharmacy and Cardiovascular Risk Considerations in Older PWH

Learn key considerations for the use of ART in older PWH. Topics include current data and recommendations on polypharmacy, drug-drug interactions, drug-disease state interactions, and cardiovascular risk considerations
Jonathan Appelbaum, MD, FACP, AAHIVS
Jens D. Lundgren, MD, DMSc
Format: Microsoft PowerPoint (.ppt)
File Size: 347 KB
Released: November 29, 2021

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings